299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03435939 (ClinicalTrials.gov)	February 15, 2022	5/2/2018	Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240	Anti-Inflammatory Therapy to Augment CFTR Rescue in CF Patients	Cystic Fibrosis	Drug: Losartan	University of Kansas Medical Center	NULL	Recruiting	18 Years	N/A	All	16	Early Phase 1	United States
2	NCT03206788 (ClinicalTrials.gov)	November 11, 2017	29/6/2017	Losartan and Inflammation in Cystic Fibrosis	Losartan as Anti-inflammatory Therapy to Augment F508del Cystic Fibrosis Transmembrane (CFTR) Recovery	Cystic Fibrosis	Drug: Losartan;Drug: placebo	University of Miami	University of Alabama at Birmingham;Children's Hospital Medical Center, Cincinnati;University of Kansas Medical Center;Cystic Fibrosis Foundation	Terminated	12 Years	N/A	All	7	Phase 2	United States